HONOLULU, Nov. 14, 2017 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) announced strong ZanthoSyn® revenues of approximately $322,000 for the third quarter of 2017 — up nearly 5 times from the second
Growth Capitalist (https://growthcapitalist.com/2017/11/cardax-reports-q3-2017-results/)
HONOLULU, Nov. 14, 2017 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) announced strong ZanthoSyn® revenues of approximately $322,000 for the third quarter of 2017 — up nearly 5 times from the second